1. Cell Cycle/DNA Damage
  2. CDK
  3. Voruciclib hydrochloride

Voruciclib hydrochloride 

Cat. No.: HY-12422A
Handling Instructions

Voruciclib hydrochloride is a clinical stage oral CDK9 inhibitor. Voruciclib hydrochloride represses expression of MCL-1 in multiple models of diffuse large B-cell lymphoma (DLBCL).

For research use only. We do not sell to patients.

Voruciclib hydrochloride Chemical Structure

Voruciclib hydrochloride Chemical Structure

CAS No. : 1000023-05-1

Size Stock
250 mg Get quote
500 mg Get quote

* Please select Quantity before adding items.

Customer Review

Top Publications Citing Use of Products
  • Biological Activity

  • Technical Information

  • Purity & Documentation

  • References

Description

Voruciclib hydrochloride is a clinical stage oral CDK9 inhibitor. Voruciclib hydrochloride represses expression of MCL-1 in multiple models of diffuse large B-cell lymphoma (DLBCL)[1].

IC50 & Target[1]

CDK9/CycT1

1.68 nM (Ki)

CDK9/cyc T2

0.626 nM (Ki)

CDK4/Cyc D1

3.96 nM (Ki)

CDK1/cycB

5.4 nM (Ki)

CDK1/cyc A

9.1 nM (Ki)

CDK6/cycD1

2.92 nM (Ki)

In Vitro

Voruciclib hydrochloride (0.5-5 µM; 6 hours) shows targeted downregulation of MCL-1 in both ABC and GCB subtypes[1].
Ki values for each target such as CDK9/cyc T2, CDK9/cyc T1, CDK6/cyc D1, CDK4/cyc D1, CDK1/cyc B, and CDK1/cyc A for Voruciclib hydrochloride are 0.626 nM, 1.68 nM, 2.92 nM, 3.96 nM, 5.4 nM, 9.1 nM, respectively[1].

Western Blot Analysis

Cell Line: U2932, RIVA, OCI-LY10 cells (ABC subtype), NU-DHL-1, SU-DHL-4, SU-DHL-6 cells (GCB subtype)[1]
Concentration: 0.5 µM, 1 µM, 2 µM, 3 µM, 4 µM, 5 µM
Incubation Time: 6 hours
Result: Showed targeted downregulation of MCL-1 in both ABC and GCB subtypes.
In Vivo

Combination of Voruciclib hydrochloride (200 mpk; Oral gavage) and Venetoclax (10 mpk, 1 mpk, 50 mpk, 25 mpk in U2932, RIVA, SU-DHL-4 and NU-DHL-1, respectively) leads to enhance tumor growth inhibition compared to either drug alone in U2932, RIVA, SU-DHL-4 (six days per week for 4 weeks), and NU-DHL-1 models (five days per week for 3 weeks) of DLBCL[1].

Animal Model: ABC subtypes (U2932, RIVA, OCI-LY10), GCB subtypes (SU-DHL-4, NU-DHL-1) xenografted in Female NOD.CB17-Prkdcscid/NCrHsd mice
Dosage: 200 mpk
Administration: Oral gavage; U2932, RIVA, SU-DHL-4 (six days per week for 4 weeks), OCI-LY10 (six days per week for 2 weeks), NU-DHL-1 (five days per week for 3 weeks)
Result: Combination with Venetoclax enhanced tumor growth inhibition in U2932, RIVA, SU-DHL-4 and NU-DHL-1 models except in OCI-LY10 model.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

References
Molecular Weight

506.30

Formula

C₂₂H₂₀Cl₂F₃NO₅

CAS No.

1000023-05-1

SMILES

Cl[H].O=C1C=C(C2=CC=C(C(F)(F)F)C=C2Cl)OC3=C([[email protected]]4[[email protected]](CO)N(C)CC4)C(O)=CC(O)=C13

Shipping

Room temperature in continental US; may vary elsewhere

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2

Inquiry Online

Your information is safe with us. * Required Fields.

Product name

 

Salutation

Applicant name *

 

Email address *

Phone number *

 

Organization name *

Country or Region *

 

Requested quantity *

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Voruciclib hydrochloride
Cat. No.:
HY-12422A
Quantity:

Voruciclib hydrochloride

Cat. No.: HY-12422A